CDC Fiscal Year 2019 Broad Agency Announcement

BAA Broad Agency AnnouncementsThe Centers for Disease Control and Prevention (CDC) works with its partners to monitor health, detect and investigate health problems, conduct research to enhance and implement prevention strategies, develop and promote sound public health policies, promote healthy behaviors, foster safe and healthful environment.

The CDC is seeking proposals for improving the state-of-the-art in the following areas:

  • Address Critical Gaps in Knowledge of the Total Preventive Benefit of Influenza Vaccines
  • Compare the Immunogenicity of Alternative Influenza Vaccines and Vaccine Strategies
  • Use Modeling and Forecasting Tools to Improve the U.S. Response to Seasonal and Pandemic Influenza
  • Virology, Surveillance and Diagnosis Branch in the Influenza Division, NCIRD, CDC is seeking technologies that will improve vaccines through in-depth virus characterization and by identifying/selecting optimal candidate vaccine viruses.
  • Develop approaches to assess the level of pre-existing immunity to influenza viruses
  • Evaluate risk and diagnosis of Pertussis
  • Building the evidence base for maternal group B streptococcal vaccine decision making
  • Understanding the underlying causes of the continued increase in reported Legionnaires’ disease cases
  • Understanding carriage of Influenza
  • Assess prevalence of complement system and Meningitis
  • New Diagnostic, Sequencing, and Metagenomic Tools for AR Detection, Microbiome Analysis, and Improved Antibiotic Use
  • International Transmission, Colonization, and Prevention of AR Pathogens
  • Domestic Transmission, Colonization, and Prevention of AR Pathogens and CDI
  • Antibiotic resistant pathogens and genes in water systems and the environment and their contribution to human infections
  • Evaluating and Improving Antibiotic Use
  • Approaches to Prevention and Control of Soil Transmitted Helminth Infections

Additional topic areas of interest and submission requirements are detailed via Solicitation Number: 75D301-19-R-67835. White papers must be received electronically by 3:00 PM EST for December 17, 2018.

From Our Partners

More From Global Biodefense